Genetic Variability and Virulence of Human Adenovirus 7
人腺病毒 7 号的遗传变异和毒力
基本信息
- 批准号:6887743
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adenoviridaeclinical researchenzyme linked immunosorbent assaygenetic straingenetic susceptibilitygenomehost organism interactionhuman tissueimmune responseimmunogeneticsimmunomodulatorsinflammationinterferonslaboratory mousenucleic acid sequencepathologic processphenotypepolymerase chain reactionrespiratory epitheliumrespiratory infectionstumor necrosis factor alphavirulencevirus geneticsvirus infection mechanismvirus replication
项目摘要
DESCRIPTION (provided by applicant): Adenovirus type 7 (Ad7) is an important human pathogen associated with severe and fatal pediatric acute pulmonary infection and outbreaks of respiratory illness among military recruits. Extensive genetic variability with more than 15 genome types described to date is a characteristic of this adenovirus serotype. Studies of genetic variation of Ad7 associated with respiratory disease in well-defined geographic areas have shown that only a few closely related genome types circulate and that one DNA variant becomes prevalent over extended periods of time after substituting for another. The emergence of novel Ad7 genome types in a given geographic area is often associated with outbreaks of severe respiratory illness, suggesting the existence of differences in pathogenic potential among Ad7 genomic variants. However, the molecular bases of these genome type substitutions or shifts are unknown. There is still a critical gap in the knowledge about the relative impact of genetic variation in nature on adenovirus virulence. Moreover, the actual determinants of the apparent higher pathogenicity of Ad7 as compared to other adenovirus serotypes have not been clearly identified. This proposal seeks to compare the genetic make up and clinically relevant phenotypes of two prevalent Ad7 genome types that constitute one of the many examples of well documented genome type shifts in nature: 7c and 7h. The central hypothesis is that the evolution of human Ad 7 in a given geographic area is driven at least in part by the selective pressure of the immune response acting upon DNA variants that differ in their genetic makeup at regions encoding immunomodulatory functions. Specific Aim 1 will determine the extent of genetic variability in the early regions of the viral genome encoding immunomodulatory products, E1 and E3. Specific Aim 2 will compare phenotypes reflecting viral fitness, transmissibility, virulence and potential for immune evasion by examining a) viral replication in lung epithelial cells, b) resistance to antiviral cytokines, c) the acute inflammatory response induced in the mouse lung after intratracheal infection and d) neutralization of viral infectivity by serotype-specific polyclonal rabbit antisera. These studies will provide insight into the molecular mechanisms underlying the emergence of predominant virulent Ad strains and will help identify candidate determinants of pathogenicity and fitness of human adenovirus type 7.
描述(由申请人提供):7 型腺病毒 (Ad7) 是一种重要的人类病原体,与严重和致命的小儿急性肺部感染以及新兵呼吸道疾病的爆发有关。迄今为止已描述的超过 15 种基因组类型的广泛遗传变异性是该腺病毒血清型的一个特征。对特定地理区域内与呼吸道疾病相关的 Ad7 遗传变异的研究表明,只有少数密切相关的基因组类型在传播,并且一种 DNA 变异在替代另一种 DNA 变异后会在很长一段时间内流行。特定地理区域中新 Ad7 基因组类型的出现通常与严重呼吸道疾病的爆发有关,这表明 Ad7 基因组变异之间存在致病潜力差异。然而,这些基因组类型取代或转变的分子基础尚不清楚。关于自然界遗传变异对腺病毒毒力的相对影响的认识仍然存在重大差距。此外,与其他腺病毒血清型相比,Ad7 明显较高致病性的实际决定因素尚未明确。该提案旨在比较两种流行的 Ad7 基因组类型的遗传组成和临床相关表型,这两种类型构成了自然界中有据可查的基因组类型转变的众多例子之一:7c 和 7h。中心假设是,人类 Ad 7 在特定地理区域的进化至少部分是由作用于 DNA 变体的免疫反应的选择性压力驱动的,这些 DNA 变体在编码免疫调节功能的区域的基因组成不同。具体目标 1 将确定编码免疫调节产物 E1 和 E3 的病毒基因组早期区域的遗传变异程度。具体目标 2 将通过检查 a) 肺上皮细胞中的病毒复制,b) 对抗病毒细胞因子的抵抗力,c) 气管内感染后在小鼠肺部诱导的急性炎症反应,以及 d) 血清型特异性多克隆兔抗血清中和病毒感染性,来比较反映病毒适应性、传播性、毒力和免疫逃避潜力的表型。这些研究将深入了解主要毒力Ad毒株出现的分子机制,并将有助于确定人类7型腺病毒致病性和适应性的候选决定因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adriana Elisa Kajon其他文献
Adriana Elisa Kajon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adriana Elisa Kajon', 18)}}的其他基金
Genetic Variability and Virulence of Human Adenovirus 7
人腺病毒 7 号的遗传变异和毒力
- 批准号:
6777938 - 财政年份:2004
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别: